Лечение пациента с острой болью в нижней части спины: эффективность и безопасность

1. Зборовский А.Б., Зборовский Б.В., Деревянко Л.И. Опыт применения Раптена рапид в лечении суставного синдрома при ревматоидном артрите. Научно-практ. ревматол. 2001; 2: 37–42.
2. Никифоров А.С., Коновалов А.Н., Гусев Е.И. Клиническая неврология. В 3 т. М.: Медицина, 2002.
3. Тихомиров В.Г. Раптена рапид в гинекологической практике. Гинекология. 2005; 7 (2): 399–402.
4. Шостак Н.А., Денисов Л.Н., Шеметов Д.А. Эффективность и переносимость Раптена рапид у больных с синдромом боли в нижней части спины. Научно-практ. ревматол. 2001; 5: 84–86.
5. Bak S, Andersen M, Tsiropoulos I et al. Risk of Stroke Associated With
Nonsteroidal Anti-Inflammatory Drugs. A Nested Case-Control Study.
Stroke 2003; 34: 379–86.
6. Barden J, Edwards J, Moore R, McQuay H. Single dose oral
diclofenac for postoperative pain. Cochrane Database Syst Rev 2004;
2: CD004768.
7. Carey T, Evans A, Hadler N et al. Acute severe low back pain. A population-
based study of prevalence and care-seeking. Spine 1996; 21:
339–44.
8. Chen Y-F, Jobanputra P, Barton P et al. Cyclooxygenase-2 selective
non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib,
rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for
osteoarthritis and rheumatoid arthritis: a systematic review and economic
evaluation. Health Technol Assess 2008; 12 (11): 1–178.
9. Chou R, Qaseem A, Snow V et al. Diagnosis and Treatment of Low
Back Pain: A Joint Clinical Practice Guideline from the American College
of Physicians and the American Pain Society. Ann Intern Med
2007; 147: 478–91.
10. Davies R, Maher C, Hancock M. A systematic review of paracetamol
for non-specific low back pain. Eur Spine J 2008 Sep 17.
11. Deyo R, Mirza S, Martin B. Back pain prevalence and visit rates:
estimates from U.S. national surveys, 2002. Spine 2006;
31: 2724–7.
12. Dreiser R, Marty M, Ionescu E et al. Relief of acute low back pain
with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg
and placebo-controlled clinical trial. Int J Clin Pharmacol Ther 2003;
41 (9): 375–85.
13. Famaey J, Bruhwyler J, Vandekerckhove K et al. Open controlled
randomised multicenter comparison of nimesulide and diclofenac in
the treatment of subacute and chronic low back pain. J Drug Assess
1998; 1: 349–68.
14. Fischer L, Schlienger R, Matter C et al. Current Use of Nonsteroidal
Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction.
Pharmacotherapy 2005; 25: 503–10.
15. Fullen B, Baxter G, O'Donovan B et al. Doctors' attitudes and
beliefs regarding acute low back pain management: A systematic
review. Pain 2008; 136 (3): 388–96.
16. Garcia Rodriguez L, Hernandez-Diaz S. Relative risk of upper gastrointestinal
complications among users of acetaminophen and nonsteroidal
anti-inflammatory drugs. Epidemiology 2001;
12: 570–6.
17. Gislason G, Jacobsen S, Rasmussen J et al. Risk of Death or Reinfarction
Associated With the Use of Selective Cyclooxygenase-2
Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs
After Acute Myocardial Infarction. Circulation 2006;
113: 2906–13.
18. Grebe W, Ionescu E, Gold M et al. A multicenter, randomized, double-
blind, double-dummy, placebo- and active-controlled, parallelgroup
comparison of diclofenac-K and ibuprofen for the treatment of
adults with influenza-like symptoms. Clin Ther 2003; 25 (2):
444–58.
19. Hagen K, Hilde G, Jamtvedt G, Winnem M. Bed rest for acute lowback
pain and sciatica. Cochrane Database Syst Rev 2004;
CD001254.
20. Hernandez-Diaz S, Rodriguez L. Association between nonsteroidal
anti-inflammatory drugs and upper gastrointestinal tract
bleeding/perforation: an overview of epidemiologic studies published
in the 1990s. Arch Intern Med 2000; 160 (14): 2093–9.
21. Hersh E, Levin L, Adamson D et al. Dose-ranging analgesic study of
Prosorb diclofenac potassium in postsurgical dental pain. Clin Ther
2004; 26 (8): 1215–27.
22. Hilde G, Hagen KB, Jamtvedt G, Winnem M. Advice to stay active
as a single treatment for low back pain and sciatica. Cochrane Database
Syst Rev 2002; CD003632.
23. Hinz B, Chevts J, Renner B et al. Bioavailability of diclofenac
potassium at low doses. Brit J Clin Pharmacol 2005; 59 (1): 80–4.
24. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in
patients taking cyclooxygenase inhibitors or conventional nonsteroidal
anti-inflammatory drugs: population based nested casecontrol
analysis. BMJ 2005; 330: 1366–72.
25. Leeson R, Harrison S, Ernst C et al. Dyloject, a novel injectable
diclofenac formulation, offers greater safety and efficacy than voltarol
for postoperative dental pain. Reg Anesth Pain Med 2007; 32 (4):
303–10.
26. Mamdani M, Rochon P, Juurlink D et al. Observational study of
upper gastrointestinal haemorrhage in elderly patients given selective
cyclo-oxygenase-2 inhibitors or conventional non-steroidal antiinflammatory
drugs. BMJ 2002; 325: 624–9.
27. Morrison A, Ramey D, van Adelsberg J, Watson D. Systematic
review of trials of the effect of continued use of oral non-selective
NSAIDs on blood pressure and hypertension. Curr Med Res Opin
2007; 23 (10): 2395–404.
28. McCormack P, Scott L. Diclofenac sodium injection (Dyloject): in
postoperative pain. Drugs 2008; 68 (1): 123–30.
29. McMahon K, Nelson M, Jones G. Treating the symptoms of
osteoarthritis-oral treatments. Aust Fam Physician 2008; 37 (3):
133–5.
30. Moore N. Diclofenac potassium 12,5 mg tablets for mild to moderate
pain and fever: a review of its pharmacology, clinical efficacy and
safety. Clin Drug Investig 2007; 27 (3): 163–95.
31. Richy F, Bruyere O, Ethgen O et al. Time dependent risk of gastrointestinal
complications induced by non-steroidal anti-inflammatory
drug use: a consensus statement using a meta-analytic
approach. Ann Rheum Dis 2004; 63 (7): 759–66.
32. Royal College of General Practitioners. Clinical Guidelines for the
Management of Acute Low Back Pain. London, Royal College of General
Practitioners, 1996 and 1999.
33. Schaffer D, Florin T, Eagle C et al. Risk of serious NSAID-related
gastrointestinal events during long-term exposure: a systematic
review. MJA 2006; 185 (9): 501–6.
34. Schlienger R, Jick H, Meier C. Use of nonsteroidal anti-inflammatory
drugs and the risk of first-time acute myocardial infarction. Brit J
Clin Pharmacol 2002; 54 (3): 327–32.
35. Schnitzer T. Update on guidelines for the treatment of chronic
musculoskeletal pain. Clin Rheumatol 2006; 25 (Suppl. 1): S22–9.
36. van Tulder M, Scholten R, Koes B, Deyo R. Non-steroidal antiinflammatory
drugs (NSAIDs) for nonspecific low back pain
(Cochrane Review). In: The Cochrane Library, Issue 4, 2000.
37. van Tulder M, Becker A, Bekkering T et al. European guidelines for
the management of acute nonspecific low back pain in primary care.
Eur Spine J 2006; 15 (Suppl. 2): S169–91.
38. Zerbini C, Ozturk Z, Grifka J et al. Efficacy of etoricoxib 60 mg/day
and diclofenac 150 mg/day in reduction of pain and disability in
patients with chronic low back pain: results of a 4-week, multinational,
randomized, double-blind study. Curr Med Res Opin 2005; 21:
2037–49.